Tähepõld, Peeter <br/><br/>
Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Mar 2003 
 - 650-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-5223 
<br/><br/><label>Standard No.: </label>10.1067/mtc.2003.36  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Antioxidants--pharmacology<br/>Coronary Circulation<br/>Disease Models, Animal<br/>Electrophoretic Mobility Shift Assay<br/>Hyperoxia--metabolism<br/>I-kappa B Proteins--analysis<br/>Immunoblotting<br/>In Vitro Techniques<br/>Ischemic Preconditioning, Myocardial--methods<br/>Male<br/>Myocardial Contraction<br/>Myocardial Reperfusion Injury--metabolism<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--analysis<br/>Oxidation-Reduction<br/>Oxygen Inhalation Therapy--methods<br/>Peptides--pharmacology<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recovery of Function<br/>Thiocarbamates--pharmacology<br/>Time Factors<br/>Transcriptional Activation<br/>Ventricular Pressure